ImmunoLytics CEO Addresses Pros and Cons of Urine Mycotoxin Testing at 2023 ISEAI Mold Symposium

November 10-11

JW Biava, ImmunoLytics CEO has conducted extensive research on the Urine Mycotoxin Testing method of measuring mold toxicity. He will be presenting his findings at the event including:

• Laboratory factors and their impact on clinical validity
• Technologies used for urine mycotoxin testing
• The pros and cons of different testing technologies

ImmunoLytics is proud to be a member of the International Society of Envrionemntally Acquired Illness. ISEAI’s mission is to reduce the human suffering caused by environmentally acquired illnesses through the integration of clinical practice, education, and research.

Health Professionals can register for the 2023 ISEAI Mold Symposium here.